Correlation Between Nurix Therapeutics and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nurix Therapeutics and Relay Therapeutics, you can compare the effects of market volatilities on Nurix Therapeutics and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and Relay Therapeutics.
Diversification Opportunities for Nurix Therapeutics and Relay Therapeutics
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Nurix and Relay is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and Relay Therapeutics go up and down completely randomly.
Pair Corralation between Nurix Therapeutics and Relay Therapeutics
Given the investment horizon of 90 days Nurix Therapeutics is expected to generate 0.96 times more return on investment than Relay Therapeutics. However, Nurix Therapeutics is 1.05 times less risky than Relay Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Relay Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 1,238 in Nurix Therapeutics on August 26, 2024 and sell it today you would earn a total of 967.00 from holding Nurix Therapeutics or generate 78.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nurix Therapeutics vs. Relay Therapeutics
Performance |
| Timeline |
| Nurix Therapeutics |
| Relay Therapeutics |
Nurix Therapeutics and Relay Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nurix Therapeutics and Relay Therapeutics
The main advantage of trading using opposite Nurix Therapeutics and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.| Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
| Relay Therapeutics vs. Eliem Therapeutics | Relay Therapeutics vs. HCW Biologics | Relay Therapeutics vs. Scpharmaceuticals | Relay Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |